These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31690660)

  • 1. ABCA7 haplodeficiency disturbs microglial immune responses in the mouse brain.
    Aikawa T; Ren Y; Yamazaki Y; Tachibana M; Johnson MR; Anderson CT; Martens YA; Holm ML; Asmann YW; Saito T; Saido TC; Fitzgerald ML; Bu G; Kanekiyo T
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23790-23796. PubMed ID: 31690660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the function of ABCA7 in Alzheimer's disease.
    Li H; Karl T; Garner B
    Biochem Soc Trans; 2015 Oct; 43(5):920-3. PubMed ID: 26517904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Abca7
    Butler CA; Mendoza Arvilla A; Milinkeviciute G; Da Cunha C; Kawauchi S; Rezaie N; Liang HY; Javonillo D; Thach A; Wang S; Collins S; Walker A; Shi KX; Neumann J; Gomez-Arboledas A; Henningfield CM; Hohsfield LA; Mapstone M; Tenner AJ; LaFerla FM; Mortazavi A; MacGregor GR; Green KN
    Alzheimers Dement; 2024 Jul; 20(7):4914-4934. PubMed ID: 38506634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease.
    Li M; Yuan Y; Hu B; Wu L
    J Mol Neurosci; 2017 Apr; 61(4):489-497. PubMed ID: 28124230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCA7-Associated Clinical Features and Molecular Mechanisms in Alzheimer's Disease.
    Qian XH; Chen SY; Liu XL; Tang HD
    Mol Neurobiol; 2023 Oct; 60(10):5548-5556. PubMed ID: 37322288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain.
    Fu Y; Hsiao JH; Paxinos G; Halliday GM; Kim WS
    J Alzheimers Dis; 2016 Sep; 54(2):569-84. PubMed ID: 27472885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing.
    Satoh K; Abe-Dohmae S; Yokoyama S; St George-Hyslop P; Fraser PE
    J Biol Chem; 2015 Oct; 290(40):24152-65. PubMed ID: 26260791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier.
    Lamartinière Y; Boucau MC; Dehouck L; Krohn M; Pahnke J; Candela P; Gosselet F; Fenart L
    J Alzheimers Dis; 2018; 64(4):1195-1211. PubMed ID: 30010117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCA7 and Pathogenic Pathways of Alzheimer's Disease.
    Aikawa T; Holm ML; Kanekiyo T
    Brain Sci; 2018 Feb; 8(2):. PubMed ID: 29401741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.
    Zhao QF; Wan Y; Wang HF; Sun FR; Hao XK; Tan MS; Tan CC; Zhang DQ; Tan L; Yu JT;
    J Alzheimers Dis; 2016 Mar; 52(2):693-703. PubMed ID: 27003212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCA7 Regulates Brain Fatty Acid Metabolism During LPS-Induced Acute Inflammation.
    Aikawa T; Ren Y; Holm ML; Asmann YW; Alam A; Fitzgerald ML; Bu G; Kanekiyo T
    Front Neurosci; 2021; 15():647974. PubMed ID: 33897360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models.
    Bamji-Mirza M; Li Y; Najem D; Liu QY; Walker D; Lue LF; Stupak J; Chan K; Li J; Ghani M; Yang Z; Rogaeva E; Zhang W
    J Alzheimers Dis; 2016 Jun; 53(3):875-92. PubMed ID: 27314524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics.
    De Roeck A; Van Broeckhoven C; Sleegers K
    Acta Neuropathol; 2019 Aug; 138(2):201-220. PubMed ID: 30903345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCA7 in Alzheimer's Disease.
    Zhao QF; Yu JT; Tan MS; Tan L
    Mol Neurobiol; 2015; 51(3):1008-16. PubMed ID: 24878767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCA7, a Genetic Risk Factor Associated with Alzheimer's Disease Risk in African Americans.
    Stepler KE; Gillyard TR; Reed CB; Avery TM; Davis JS; Robinson RAS
    J Alzheimers Dis; 2022; 86(1):5-19. PubMed ID: 35034901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ABCA7 in Human Health and in Alzheimer's Disease.
    Dib S; Pahnke J; Gosselet F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease.
    De Roeck A; Duchateau L; Van Dongen J; Cacace R; Bjerke M; Van den Bossche T; Cras P; Vandenberghe R; De Deyn PP; Engelborghs S; Van Broeckhoven C; Sleegers K;
    Acta Neuropathol; 2018 Jun; 135(6):827-837. PubMed ID: 29589097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.